Abstract
44063 Short Term Efficacy and Racial and Ethnic Diversity in Risankizumab Phase 3 Clinical Trials for Treatment of Moderate-to-Severe Plaque Psoriasis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
